Abstract
Background: In patients treated with curative surgery for colorectal cancer, the single-phase (portal phase) abdomen-pelvic computed tomography (CT) follow-up is routinely performed to detect any recurrent lesions.
Objective: The objective of this study is to evaluate CT features implying metastasis in newly appearing hepatic lesions on single-phase CT after colorectal cancer surgery.
Methods: Of 1,227 patients who underwent curative colorectal surgery between 2011 and 2014, 267 patients with new hepatic lesions on follow-up single-phase CT (metastasis, n=192; benign, n=75) were included. The CT features of the hepatic lesions were analyzed by two radiologists retrospectively, and clinical information, including carcinoembryonic antigen (CEA) level was also reviewed. The risk factors for hepatic metastasis were evaluated by multivariable logistic regression.
Results: In this study, independent CT features associated with metastasis were spherical shape (p < 0.001), circumscribed margin (p = 0.021), heterogeneous attenuation (p = 0.024) and bulging appearance (p = 0.007). Among the clinical factors, increased CEA level (p = 0.013), higher preoperative stage (p = 0.014) and lymphovascular invasion (p = 0.003) were associated with metastasis. However, on multivariable analysis, spherical shape was the only significant predictive factor for hepatic metastasis. The diagnostic performance of ‘spherical shape’ for detection of hepatic metastasis showed an accuracy of 84.6%, sensitivity of 83.9%, and specificity of 86.7%.
Conclusion: Specific single-phase CT features could be useful in distinguishing hepatic metastasis from benign, resulting in continuing routine CT follow-up without liver magnetic resonance imaging (MRI) when metastasis is unlikely.
Keywords: colorectal neoplasm, neoplasm metastasis, computed tomography, spherical shape, circumscribed margin, heterogenous attenuation, bulging appearance
Graphical Abstract
[1]
Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol 2021; 14(10): 101174.
[http://dx.doi.org/10.1016/j.tranon.2021.101174] [PMID: 34243011]
[http://dx.doi.org/10.1016/j.tranon.2021.101174] [PMID: 34243011]
[2]
Valderrama TAI, Barrera MB, Ceballos VJC, Montalvo JEE. Hepatic metastasis from colorectal cancer. Euroasian J Hepatogastroenterol 2017; 7(2): 166-75.
[http://dx.doi.org/10.5005/jp-journals-10018-1241] [PMID: 29201802]
[http://dx.doi.org/10.5005/jp-journals-10018-1241] [PMID: 29201802]
[3]
Vatandoust S, Price TJ, Karapetis CS. Colorectal cancer: Metastases to a single organ. World J Gastroenterol 2015; 21(41): 11767-76.
[http://dx.doi.org/10.3748/wjg.v21.i41.11767] [PMID: 26557001]
[http://dx.doi.org/10.3748/wjg.v21.i41.11767] [PMID: 26557001]
[4]
Asato N, Tsurusaki M, Sofue K, et al. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases. Jpn J Radiol 2017; 35(4): 197-205.
[http://dx.doi.org/10.1007/s11604-017-0622-2] [PMID: 28251499]
[http://dx.doi.org/10.1007/s11604-017-0622-2] [PMID: 28251499]
[5]
Fehrenbach U, Auer TA, Schöning W, et al. Postoperative Single-Sequence (PoSSe) MRI: Imaging work-up for CT-guided or endoscopic drainage indication of collections after hepatopancreaticobiliary surgery. Abdom Radiol 2021; 46(7): 3418-27.
[http://dx.doi.org/10.1007/s00261-021-02955-7] [PMID: 33590307]
[http://dx.doi.org/10.1007/s00261-021-02955-7] [PMID: 33590307]
[6]
Krishna S, Murray CA, McInnes MD, et al. CT imaging of solid renal masses: Pitfalls and solutions. Clin Radiol 2017; 72(9): 708-21.
[http://dx.doi.org/10.1016/j.crad.2017.05.003] [PMID: 28592361]
[http://dx.doi.org/10.1016/j.crad.2017.05.003] [PMID: 28592361]
[7]
Joshi AR, Basantani AS, Patel TC. Role of CT and MRI in abdominal tuberculosis. Curr Radiol Rep 2014; 2(10): 66.
[http://dx.doi.org/10.1007/s40134-014-0066-8]
[http://dx.doi.org/10.1007/s40134-014-0066-8]
[8]
Muhi A, Ichikawa T, Motosugi U, et al. Diagnosis of colorectal hepatic metastases: Comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011; 34(2): 326-35.
[http://dx.doi.org/10.1002/jmri.22613] [PMID: 21780227]
[http://dx.doi.org/10.1002/jmri.22613] [PMID: 21780227]
[9]
Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: A meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010; 257(3): 674-84.
[http://dx.doi.org/10.1148/radiol.10100729] [PMID: 20829538]
[http://dx.doi.org/10.1148/radiol.10100729] [PMID: 20829538]
[10]
Alabousi M, McInnes MDF, Salameh JP, et al. MRI vs. CT for the detection of liver metastases in patients with pancreatic carcinoma: A comparative diagnostic test accuracy systematic review and meta‐analysis. J Magn Reson Imaging 2021; 53(1): 38-48.
[http://dx.doi.org/10.1002/jmri.27056] [PMID: 31943576]
[http://dx.doi.org/10.1002/jmri.27056] [PMID: 31943576]
[11]
Sahani DV, Kalva SP. Imaging the liver. Oncologist 2004; 9(4): 385-97.
[http://dx.doi.org/10.1634/theoncologist.9-4-385] [PMID: 15266092]
[http://dx.doi.org/10.1634/theoncologist.9-4-385] [PMID: 15266092]
[12]
Canellas R, Patel MJ, Agarwal S, Sahani DV. Lesion detection performance of an abbreviated gadoxetic acid–enhanced MRI protocol for colorectal liver metastasis surveillance. Eur Radiol 2019; 29(11): 5852-60.
[http://dx.doi.org/10.1007/s00330-019-06113-y] [PMID: 30888485]
[http://dx.doi.org/10.1007/s00330-019-06113-y] [PMID: 30888485]
[13]
Wu XZ, Ma F, Wang XL. Serological diagnostic factors for liver metastasis in patients with colorectal cancer. World J Gastroenterol 2010; 16(32): 4084-8.
[http://dx.doi.org/10.3748/wjg.v16.i32.4084] [PMID: 20731024]
[http://dx.doi.org/10.3748/wjg.v16.i32.4084] [PMID: 20731024]
[14]
Yuan H, Dong Q, Zheng B, Hu X, Xu JB, Tu S. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: A systematic review and meta-analysis. Oncotarget 2017; 8(28): 46565-79.
[http://dx.doi.org/10.18632/oncotarget.15425] [PMID: 28430621]
[http://dx.doi.org/10.18632/oncotarget.15425] [PMID: 28430621]
[15]
Rasouli MA, Moradi G, Roshani D, Nikkhoo B, Ghaderi E, Ghaytasi B. Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran. Medicine 2017; 96(6): e5941.
[http://dx.doi.org/10.1097/MD.0000000000005941] [PMID: 28178134]
[http://dx.doi.org/10.1097/MD.0000000000005941] [PMID: 28178134]
[16]
Oh JG, Choi SY, Lee MH, et al. Differentiation of hepatic abscess from metastasis on contrast-enhanced dynamic computed tomography in patients with a history of extrahepatic malignancy: Emphasis on dynamic change of arterial rim enhancement. Abdom Radiol 2019; 44(2): 529-38.
[http://dx.doi.org/10.1007/s00261-018-1766-y] [PMID: 30196363]
[http://dx.doi.org/10.1007/s00261-018-1766-y] [PMID: 30196363]
[17]
Ichikawa S, Motosugi U, Suzuki T, Shimizu T, Onishi H. Imaging features of hepatic inflammatory pseudotumor: Distinction from colorectal liver metastasis using gadoxetate disodium-enhanced magnetic resonance imaging. Abdom Radiol 2020; 45(8): 2400-8.
[http://dx.doi.org/10.1007/s00261-020-02575-7] [PMID: 32468212]
[http://dx.doi.org/10.1007/s00261-020-02575-7] [PMID: 32468212]
[18]
Freitas PS, Janicas C, Veiga J, Matos AP, Herédia V, Ramalho M. Imaging evaluation of the liver in oncology patients: A comparison of techniques. World J Hepatol 2021; 13(12): 1936-55.
[http://dx.doi.org/10.4254/wjh.v13.i12.1936] [PMID: 35069999]
[http://dx.doi.org/10.4254/wjh.v13.i12.1936] [PMID: 35069999]
[19]
Paulatto L, Dioguardi BM, Sartoris R, et al. Colorectal liver metastases: Radiopathological correlation. Insights Imaging 2020; 11(1): 99.
[http://dx.doi.org/10.1186/s13244-020-00904-4] [PMID: 32844319]
[http://dx.doi.org/10.1186/s13244-020-00904-4] [PMID: 32844319]
[20]
Song S, Li Z, Niu L, et al. Hypervascular hepatic focal lesions on dynamic contrast-enhanced CT: Preliminary data from arterial phase scans texture analysis for classification. Clin Radiol 2019; 74(8): 653.e11-8.
[http://dx.doi.org/10.1016/j.crad.2019.05.010] [PMID: 31208725]
[http://dx.doi.org/10.1016/j.crad.2019.05.010] [PMID: 31208725]
[21]
Park SH, Han K. Methodologic guide for evaluating clinical performance and effect of artificial intelligence technology for medical diagnosis and prediction. Radiology 2018; 286(3): 800-9.
[http://dx.doi.org/10.1148/radiol.2017171920] [PMID: 29309734]
[http://dx.doi.org/10.1148/radiol.2017171920] [PMID: 29309734]
[22]
Park JE, Park SY, Kim HJ, Kim HS. Reproducibility and generalizability in radiomics modeling: Possible strategies in radiologic and statistical perspectives. Korean J Radiol 2019; 20(7): 1124-37.
[http://dx.doi.org/10.3348/kjr.2018.0070] [PMID: 31270976]
[http://dx.doi.org/10.3348/kjr.2018.0070] [PMID: 31270976]
[23]
Bae H, Lee H, Kim S, et al. Radiomics analysis of contrast-enhanced CT for classification of hepatic focal lesions in colorectal cancer patients: Its limitations compared to radiologists. Eur Radiol 2021; 31(11): 8786-96.
[http://dx.doi.org/10.1007/s00330-021-07877-y] [PMID: 33970307]
[http://dx.doi.org/10.1007/s00330-021-07877-y] [PMID: 33970307]
[24]
Mirón MR, Arildskov AR, Bruun FJ, et al. What genetics can do for oncological imaging: A systematic review of the genetic validation data used in radiomics studies. Int J Mol Sci 2022; 23(12): 6504.
[http://dx.doi.org/10.3390/ijms23126504] [PMID: 35742947]
[http://dx.doi.org/10.3390/ijms23126504] [PMID: 35742947]
[25]
Heiken JP. Distinguishing benign from malignant liver tumours. Cancer Imaging 2007; 7(Special issue A): S1.: 14.
[http://dx.doi.org/10.1102/1470-7330.2007.9084]
[http://dx.doi.org/10.1102/1470-7330.2007.9084]
[26]
Marrero JA, Ahn J, Reddy RK. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 2014; 109(9): 1328-47.
[http://dx.doi.org/10.1038/ajg.2014.213] [PMID: 25135008]
[http://dx.doi.org/10.1038/ajg.2014.213] [PMID: 25135008]
[27]
Kovač JD, Janković A, Đikić RA, Grubor N, Antić A, Dugalić V. Imaging spectrum of intrahepatic mass-forming cholangiocarcinoma and its mimickers: How to differentiate them using MRI. Curr Oncol 2022; 29(2): 698-723.
[http://dx.doi.org/10.3390/curroncol29020061] [PMID: 35200560]
[http://dx.doi.org/10.3390/curroncol29020061] [PMID: 35200560]
[28]
Kim GM, Won JY, Kim MD, et al. Cryoablation of hepatocellular carcinoma with high-risk for percutaneous ablation: Safety and efficacy. Cardiovasc Intervent Radiol 2016; 39(10): 1447-54.
[http://dx.doi.org/10.1007/s00270-016-1384-4] [PMID: 27256103]
[http://dx.doi.org/10.1007/s00270-016-1384-4] [PMID: 27256103]
[29]
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17(6): 1471-4.
[31]
Kimura K, Itoh S, Kurihara T, et al. Predictors of benign status in liver tumors under 3cm in diameter misdiagnosed as hepatocellular carcinoma. Anticancer Res 2016; 36(2): 793-7.
[PMID: 26851041]
[PMID: 26851041]
[32]
McHugh ML. Interrater reliability: The kappa statistic. Biochem Med 2012; 22(3): 276-82.
[http://dx.doi.org/10.11613/BM.2012.031] [PMID: 23092060]
[http://dx.doi.org/10.11613/BM.2012.031] [PMID: 23092060]
[33]
Vera R, Aparicio J, Carballo F, et al. Recommendations for follow up of colorectal cancer survivors. Clin Transl Oncol 2019; 21(10): 1302-11.
[http://dx.doi.org/10.1007/s12094-019-02059-1] [PMID: 30762206]
[http://dx.doi.org/10.1007/s12094-019-02059-1] [PMID: 30762206]
[34]
Oh JS, Koea JB. Radiation risks associated with serial imaging in colorectal cancer patients: Should we worry? World J Gastroenterol 2014; 20(1): 100-9.
[http://dx.doi.org/10.3748/wjg.v20.i1.100] [PMID: 24415862]
[http://dx.doi.org/10.3748/wjg.v20.i1.100] [PMID: 24415862]
[35]
Hur J, Park MS, Yu JS, Lim JS, Hong SW, Kim KW. Focal eosinophilic necrosis versus metastasis in the liver: The usefulness of two-phase dynamic CT. AJR Am J Roentgenol 2005; 184(4): 1085-90.
[http://dx.doi.org/10.2214/ajr.184.4.01841085] [PMID: 15788577]
[http://dx.doi.org/10.2214/ajr.184.4.01841085] [PMID: 15788577]
[36]
Jang HJ, Lee WJ, Lee SJ, Kim SH, Lim HK, Lim JH. Focal eosinophilic necrosis of the liver in patients with underlying gastric or colorectal cancer: CT differentiation from metastasis. Korean J Radiol 2002; 3(4): 240-4.
[http://dx.doi.org/10.3348/kjr.2002.3.4.240] [PMID: 12514341]
[http://dx.doi.org/10.3348/kjr.2002.3.4.240] [PMID: 12514341]
[37]
Jung SW, Kim DS, Yu YD, Han JH, Suh SO. Risk factors for cancer recurrence or death within 6 months after liver resection in patients with colorectal cancer liver metastasis. Ann Surg Treat Res 2016; 90(5): 257-64.
[http://dx.doi.org/10.4174/astr.2016.90.5.257] [PMID: 27186570]
[http://dx.doi.org/10.4174/astr.2016.90.5.257] [PMID: 27186570]
[38]
Lintoiu UB, Tulin A, Constantinoiu S. Recurrence after hepatic resection in colorectal cancer liver metastasis -Review article-. J Med Life 2015; 8(Spec Issue): 12-4.
[PMID: 26361505]
[PMID: 26361505]
[39]
Vercruysse V, Van Hoe L. Eosinophilic liver disease mimicking hepatic metastases. J Belg Soc Radiol 2017; 101(1): 18.
[http://dx.doi.org/10.5334/jbr-btr.1235] [PMID: 30039010]
[http://dx.doi.org/10.5334/jbr-btr.1235] [PMID: 30039010]
[40]
Lee T, Lee YS, Yoon SY, et al. Clinical characteristics that distinguish eosinophilic organ infiltration from metastatic nodule development in cancer patients with eosinophilia. World J Surg Oncol 2012; 10(1): 175.
[http://dx.doi.org/10.1186/1477-7819-10-175] [PMID: 22929225]
[http://dx.doi.org/10.1186/1477-7819-10-175] [PMID: 22929225]
Article Metrics
1